TY  - CONF

T1  - The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.

JO  - ARTHRITIS AND RHEUMATISM

PY  - 2003/09/01

AU  - Bansback NJ

AU  - Brennan A

AU  - Ghatnekar O

AU  - Sengupta N

AU  - Chang KY

AU  - Hansen M

ED  - 

VL  - 48

IS  - 9

SP  - S611

EP  - S611

Y2  - 2024/12/22

ER  -